v3.26.1
Basic and Diluted Loss Per Share
 3 Months Ended
Mar. 31, 2026
Basic and Diluted Loss Per Share [Abstract]  
BASIC AND DILUTED LOSS PER SHARE

NOTE 8 – BASIC AND DILUTED LOSS PER SHARE

 

Basic loss per share is computed on the basis of the net loss for the period divided by the weighted average number of shares of Common Stock outstanding during the period, fully vested warrants with no exercise price for the Company’s Common Stock, fully vested pre-funded warrants for the Company’s Common Stock at an exercise price of $0.01 per share and $0.0001 per share and A&R Warrants at an exercise price of $0.0001 per share, as the Company considers these shares to be exercised for little to no additional consideration.

 

Diluted loss per share is based upon the weighted average number of shares of Common Stock and of potential shares of Common Stock outstanding when dilutive. Potential shares of Common Stock equivalents include outstanding stock options and warrants, which are included under the treasury stock method when dilutive.

 

The basic and diluted net loss per share and weighted average number of shares of Common Stock used in the calculation of basic and diluted net loss per share are as follows:

 

   Three Months Ended
March 31,		 
   2026   2025 (*) 
Basic and dilutedloss per share of common stock        
Numerator:        
Net loss   19,140    7,659 
Preferred dividends on Series Y Convertible Preferred Stock   85    
-
 
Numerator   19,225    7,659 
Denominator:          
Number of shares of common stock outstanding   2,357,591    1,093,177 
Number of shares upon pre-funded warrants and A&R Warrants exercise   246,216    122,760 
Number of shares upon Fully vested Warrants exercise   
-
    16 
Total weighted-average number of shares of common stock, shares upon pre-funded warrants, A&R Warrants and Fully vested Warrants exercise used in computing basic and diluted loss per share   2,603,807    1,215,953 
Basic and diluted loss per share of common stock   7.38    6.27 

The calculation of diluted loss per share for the three months ended March 31, 2026 and March 31, 2025, does not include the shares underlying the following financial instruments because their effect would be anti-dilutive:

 

   Three Months Ended
March 31,		 
   2026   2025 
         
Options   41,096     101,246(*)
Warrants   959,704     959,704(*)
Contingent shares   10,526     10,526(*)
Redeemable Convertible Preferred Shares   776,383     777,553(*)

 

(*) All share amounts have been retroactively adjusted to reflect a 1-for-19 reverse share split as discussed in Note 7A.